Rheumatology International

, Volume 39, Issue 4, pp 657–662 | Cite as

Early arthritis clinic is effective for rheumatoid and psoriatic arthritides

  • M. K. NisarEmail author
Observational Research



Early arthritis clinics (EACs) have been well established since 1980s. Most of the data for their effectiveness comes from rheumatoid arthritis (RA) management and is largely limited to process outcomes. There is little evidence that such clinics improve clinical outcomes particularly for psoriatic arthritis (PsA). We examined whether EACs provide better outcomes irrespective of final arthritis diagnosis.


A 52-week prospective observational study of all inflammatory arthritis patients presenting to early arthritis service at our secondary care hospital in 2016 was undertaken. A protocolised approach to the early initiation of therapy (within 3 weeks) and 6-weekly review of treatment outcomes was embedded irrespective of the arthritis diagnosis. Statistical analysis was undertaken using Mann–Whitney U test for disease activity scores to ascertain the significance of outcomes.


Of 1884 patients referred, 482 (25.5%) were triaged into EACs based on set criteria. 159 (64.3%) had RA, 55 (22%) with PsA and 33 had other inflammatory arthritides. Mean DAS28 for RA at first visit was 4.65 (0.6–8.0). Treating to target achieved DAS28 remission for 84 (53.5%) and low disease activity (LDA) for a further 44 (34%). Median time to achieve remission or LDA was 20 weeks (0–52 weeks). Mean tender (TJ) and swollen joint (SJ) counts for PsA at first visit were 8.2 (1–35) and 3.5 (0–14), respectively [n = 55]. The patient (PtGA) and physician (PhGA) global assessments mean were 3.0 and 2.9 (1–5). Target [TJ and SJ ≤ 2] was achieved for 38 patients (69%) and good PsARC response for a further four (7%). Median time to achieve the target or good response was 22 weeks (0–48 weeks). Final TJ and SJ mean was significantly better at 1.2 (0–4) and 0.3 (0–2) [p < 0.0001] with similar improvement in PtGA [mean 1.8 (1–4)] and PhGA [mean 1.6 (1–3)].


Dedicated EACs help achieve good clinical outcomes in majority of patients with RA and PsA. Nearly 80% of our cohort attained the target or good disease response in less than 6 months. This was despite a significant delay in patients presenting to their GPs and moderately high disease activity.


Early arthritis Clinic Psoriatic arthritis Outcomes 


Author contributions

Concept: MKN; design: MKN; data collection and/or processing: MKN; analysis and/or interpretation: MKN; literature search: MKN; writing: MKN.


None received.

Compliance with ethical standards

Conflict of interest

No author has any conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approved on 30 Aug 2016 by Luton and Dunstable University Hospital (approval number 8/2015-16/Medicine/Rheumatology).


  1. 1.
    Lard LR, Visser H, Speyer I et al (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111:446–451CrossRefGoogle Scholar
  2. 2.
    O’DELL JR (2002) Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 46:283–285CrossRefGoogle Scholar
  3. 3.
    Combe B, Landewe R, Lukas C et al (2007) EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66:34–45CrossRefGoogle Scholar
  4. 4.
    Combe B, Landewe R, Daien CI et al (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis 76:948–959CrossRefGoogle Scholar
  5. 5.
    National Institute for Health and Care Excellence (2013). Rheumatoid Arthritis: NICE Quality Standard [QS33] 2013. Accessed 13 Jan 2019
  6. 6.
    Emery P, Gough A (1991) Why early arthritis clinics? Br J Rheumatol 30:241–242.Google Scholar
  7. 7.
    BSR National Clinical audit for rheumatoid and early inflammatory arthritis 2nd annual report 2016. Accessed 13 Jan 2019
  8. 8.
    Descalzo M, Carbonell J, Gonzalezalvaro I et al (2012) SERAP and PROAR Study Groups: effectiveness of a clinical practice intervention in early rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:321–330CrossRefGoogle Scholar
  9. 9.
    Coates LC, Helliwell PS (2017) Psoriatic arthritis: state of the art review. Clin Med 17:65–70CrossRefGoogle Scholar
  10. 10.
    Coates LC, Navarro-Coy N, Brown SR et al (2013) The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord 14:101CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Goeb V, Smolen J, Emery P, Marzo-Ortega H (2009) Early inflammatory clinics. Experience with early arthritis/back pain clinics. Clin Exp Rheumatol 27:S74–S79Google Scholar
  12. 12.
    Yiannopoulos G, Daoussis D, Melissaropoulos K, Tsouni C, Andonopoulos AP (2015) Evolution of undifferentiated arthritis: a ten year experience from the early arthritis clinic of a tertiary care hospital. Clin Exp Rheumatol 33:341–346Google Scholar
  13. 13.
    Govoni M, Scire CA, Manara M et al (2013) Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review. Clin Exp Rheumatol 31:443–451Google Scholar
  14. 14.
    Haroon M, Gallagher P, Fitzgerald O (2015) Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74:1045–1050CrossRefGoogle Scholar
  15. 15.
    Klareskog L, Nordmark B, Lindblad S (2001) On the organisation of an early arthritis clinic. Best Pract Res Clin Rheumatol 15:1–15CrossRefGoogle Scholar
  16. 16.
    Coates LC, Kavanaugh A, Mease PJ et al (2016) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 68:1060–1071Google Scholar
  17. 17.
    Gossec L, Smolen JS, Ramiro S et al (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75:499–510CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Rheumatology DepartmentLuton and Dunstable University Hospital NHSFTLutonUK

Personalised recommendations